In a statement last week Governor Bev Perdue said Hospira plans to make the investment – which could increase to $270m over the next decade – to improve the facility in a project supported by a $645,000 grant from the One North Carolina fund.
News of the investment comes just a few months after Hospira successfully resolved significant and long running quality problems at the facility that forced it to halt operations, severely impacting its contract manufacturing business.
The firm is due to speak to investors at the Morgan Stanley Global Healthcare Conference and UBS Global Life Sciences conferences in September. Outsourcing-pharma.com will listen in to update readers on the investment plans.